Ted William Karkus Sells 424,789 Shares of ProPhase Labs Inc (PRPH) Stock

ProPhase Labs Inc (NASDAQ:PRPH) CEO Ted William Karkus sold 424,789 shares of ProPhase Labs stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $2.30, for a total transaction of $977,014.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Ted William Karkus also recently made the following trade(s):

  • On Friday, September 29th, Ted William Karkus sold 364,950 shares of ProPhase Labs stock. The stock was sold at an average price of $2.30, for a total transaction of $839,385.00.

ProPhase Labs Inc (PRPH) opened at $2.15 on Thursday. ProPhase Labs Inc has a 1 year low of $1.78 and a 1 year high of $2.45. The company has a market cap of $26.60, a P/E ratio of 2.76 and a beta of 0.16.

ProPhase Labs (NASDAQ:PRPH) last announced its quarterly earnings data on Monday, November 13th. The company reported ($0.05) EPS for the quarter. ProPhase Labs had a net margin of 307.58% and a return on equity of 40.36%. The company had revenue of $3.04 million for the quarter.

ProPhase Labs declared that its Board of Directors has approved a share buyback plan on Friday, November 10th that authorizes the company to buyback 1,700,000 outstanding shares. This buyback authorization authorizes the company to repurchase shares of its stock through a tender offer. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

Separately, ValuEngine downgraded shares of ProPhase Labs from a “hold” rating to a “sell” rating in a research report on Thursday, October 5th.

ILLEGAL ACTIVITY WARNING: “Ted William Karkus Sells 424,789 Shares of ProPhase Labs Inc (PRPH) Stock” was first published by Week Herald and is the property of of Week Herald. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://weekherald.com/2017/12/28/ted-william-karkus-sells-424789-shares-of-prophase-labs-inc-prph-stock.html.

ProPhase Labs Company Profile

ProPhase Labs, Inc manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company’s products include TK Supplements and ORXx Complete.

Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply